Interval of injections of intramuscular depot medroxyprogesterone acetate in the long-term treatment of endometriosis-associated pain: A randomized comparative trial

Gynecologic and Obstetric Investigation

Volumn 68, Issue 2, 2009, Pages 116-121

  Cheewadhanaraks, Sopon ^a   Peeyananjarassri, Krantarat ^a   Choksuchat, Chainarong ^a   Dhanaworavibul, Kriengsak ^a   Choobun, Thanapan ^a   Bunyapipat, Sathana ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Depot medroxyprogesterone acetate; Endometriosis; Pain

Indexed keywords

ESTRADIOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE ACETATE;

ACNE; ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; BREAKTHROUGH BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; DYSMENORRHEA; DYSPAREUNIA; ENDOMETRIOSIS; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MASTALGIA; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SCORING SYSTEM; THERAPY EFFECT; TRANSVAGINAL ECHOGRAPHY; TREATMENT OUTCOME; TREATMENT RESPONSE; VAGINAL DRYNESS; VISUAL ANALOG SCALE; WEIGTH GAIN;

ADULT; DELAYED-ACTION PREPARATIONS; DRUG ADMINISTRATION SCHEDULE; ENDOMETRIOSIS; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MEDROXYPROGESTERONE ACETATE; PAIN; PATIENT SATISFACTION; PATIENT SELECTION; PREMENOPAUSE; TIME FACTORS;

EID: 67649199934     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000226090     Document Type: Article

References (27)

1. Olive DL, Schwartz LB: Endometriosis. N Engl J Med 1993; 328: 1759-1769.
2. Vigano P, Parazzini F, Somigliana E, Vercellini P: Endometriosis: epidemiology and aetiological factors. Best Pract Res Clin Obstet Gynaecol 2004; 18: 177-200.
3. Child TJ, Tan SL: Endometriosis: aetiology, pathogenesis and treatment. Drugs 2001; 61: 1735-1750.
4. Chwalisz K, Garg R, Brenner RM, Schubert G, Elger W: Selective progesterone receptor modulators: a novel therapeutic concept in endometriosis. Ann NY Acad Sci 2002; 955: 373-388. (Pubitemid 34271095)
5. Schweppe KW: Current place of progestins in the treatment of endometriosis-related complaints. Gynecol Endocrinol 2001; 15(suppl 6):22-28. (Pubitemid 33731348)
6. Vercellini P, Fedele L, Pietropaolo G, Frontino G, Somigliana E, Crosignani PG: Progestogens for endometriosis: forward to the past. Hum Reprod Update 2003; 9: 387-396.
7. Kaunitz AM: Long-acting injectable contraception with depot medroxyprogesterone acetate. Am J Obstet Gynecol 1994; 170: 1543-1549. (Pubitemid 24185449)
8. Jain J, Jakimiuk AJ, Bode FR, Ross D, Kaunitz AM: Contraceptive efficacy and safety of DMPA-SC. Contraception 2004; 70: 269-275.
9. Vercellini P, De Giorgi O, Oldani S, Cortesi I, Panazza S, Crosignani PG: Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis. Am J Obstet Gynecol 1996; 175: 396-401. (Pubitemid 26390998)
10. Arowojolu AO: Treatment of endometriosis with depot medroxyprogesterone acetate: a preliminary experience. Afr J Med Med Sci 2000; 29: 55-58.
11. Hornstein MD, Barbieri RL: Endometriosis; in Ryan KJ, Berkowitz RS, Barbieri RL, Dunaif A (ed): Kistner's Gynecology and Women's Health, ed 7. St Louis, Mosby, 1999, pp 492-518.
12. Bergqvist A, Theorell T: Changes in quality of life after hormonal treatment of endometriosis. Acta Obstet Gynecol Scand 2001; 80: 628-637. (Pubitemid 32631458)
13. Telimaa S, Puolakka J, Ronnberg L, Kauppila A: Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis. Gynecol Endocrinol 1987; 1: 13-23.
14. Luciano AA, Turksoy RN, Carleo J: Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis. Obstet Gynecol 1988; 72: 323-327. (Pubitemid 18206751)
15. Mahutte NG, Arici A: Medical management of endometriosis-associated pain. Obstet Gynecol Clin N Am 2003; 30: 133-150.
16. American Fertility Society: Revised American Fertility Society classification of endometriosis, 1985. Fertil Steril 1985; 43: 351-352.
17. Biberoglu KO, Behrman SJ: Dosage aspects of danazol therapy in endometriosis: shortterm and long-term effectiveness. Am J Obstet Gynecol 1981; 139: 645-654.
18. Surrey ES, Schoolcraft WB: Management of endometriosis-associated infertility. Obstet Gynecol Clin N Am 2003; 30: 193-208.
19. Vercellini P, Fedele L, Aimi G, Pietropaolo G, Consonni D, Crosignani PG: Association between endometriosis stage, lesion type, patient characteristics and severity of pelvic pain symptoms: a multivariate analysis of over 1,000 patients. Hum Reprod 2007; 22: 266-271. (Pubitemid 44942695)
20. Crosignani PG, Luciano A, Ray A, Bergqvist A: Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain. Hum Reprod 2006; 21: 248-256. (Pubitemid 41794318)
21. Schlaff WD, Carson SA, Luciano A, Ross D, Bergqvist A: Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain. Fertil Steril 2006; 85: 314-325. (Pubitemid 43170902)
22. Pelkman CL, Chow M, Heinbach RA, Rolls BJ: Short-term effects of a progestational contraceptive drug on food intake, resting energy expenditure, and body weight in young women. Am J Clin Nutr 2001; 73: 19-26. (Pubitemid 32016810)
23. Kaunitz AM, Arias R, McClung M: Bone density recovery after depot medroxyprogesterone acetate injectable contraception use. Contraception 2008; 77: 67-76.
24. Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM: Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception. Arch Pediatr Adolesc Med 2005; 159: 139-144. (Pubitemid 40194179)
25. Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM: Injectable hormone contraception and bone density: results from a prospective study. Epidemiology 2002; 13: 581-587. (Pubitemid 34898508)
26. Clark MK, Sowers MR, Nichols S, Levy B: Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate. Fertil Steril 2004; 82: 1580-1586. (Pubitemid 39611386)
27. Shaarawy M, El-Mallah SY, Seoudi S, Hassan M, Mohsen IA: Effects of the long-term use of depot medroxyprogesterone acetate as hormonal contraceptive on bone mineral density and biochemical markers of bone remodeling. Contraception 2006; 74: 297-302. (Pubitemid 44373881)